Alvotech Holdings S.A.: Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company

Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets. Biosimilars are therapeutic equivalents to

Related Keywords

Germany ,California ,United States ,Reykjavik ,C10 ,Iceland ,Japan ,United Kingdom ,Stephanie Carrington ,Howard Marks ,Robert Wessman ,Abu Dhabi ,Los Angeles ,Sean Leous ,Mark Levick ,Zaid Pardesi ,King Spalding ,Nasdaq ,Family Office ,Deutsche Bank Securities ,Shareholders Of Oaktree Acquisition Corp ,Marion Bank ,Alvotech Holdings Sa ,Oaktree Life Sciences Lending ,Shearman Sterling ,Morgan Stanley Co ,Neither Oaktree Acquisition Corp ,Company Overview ,Temasek ,Credit Suisse ,Oaktree Acquisition Corp ,Exchange Commission ,Cooley United Kingdom ,Citigroup Global Markets Inc ,Alvotech At Oaktree Acquisition Corp ,Suvretta Capital ,Farallon Capital Management ,Sculptor Capital Management ,Arctica Finance ,Oaktree Acquisition ,Oaktree Capital Management ,Managing Director ,Aztiq Pharma Partners ,Fuji Pharma ,Baxter Healthcare ,Business Combination Agreement ,United States Securities ,Bank Securities ,Morgan Stanley ,Citigroup Global Markets ,Current Report ,Life Sciences Lending ,Registration Statement ,Grand Avenue ,Note Regarding Forward Looking ,Securities Act ,Evaluate Pharma ,Alvotech ,Oldings ,0aktree ,Cquisition ,Orp ,Nnounce ,Berger ,Agreement ,Create ,Reading ,Publicly ,Raded ,Lobal ,Iopharmaceutical ,Company ,